Ardelyx ARDX Product supply revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's product supply revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's product supply revenue — total revenues?
- Ardelyx (ARDX) reported product supply revenue — total revenues of $354K in Q1 2026.
- How has Ardelyx's product supply revenue — total revenues changed year-over-year?
- Ardelyx's product supply revenue — total revenues increased by 39.4% year-over-year, from $254K to $354K.
- What is the long-term trend for Ardelyx's product supply revenue — total revenues?
- Over 4 years (2021 to 2025), Ardelyx's product supply revenue — total revenues has grown at a 103.7% compound annual growth rate (CAGR), from $922K to $15.88M.
- What does product supply revenue — total revenues mean?
- This metric represents the total revenue generated specifically from the sale and distribution of proprietary pharmaceutical products. It reflects the commercial success and market adoption of the company's therapeutic offerings within its target patient populations. Tracking this revenue stream is essential for evaluating the transition from clinical development to commercial-stage operations and assessing the scalability of the company's product portfolio.